Crk and CrkL are cellular counterparts of the viral oncoprotein v-Crk. Crk and CrkL are overexpressed in many types of human cancer, correlating with poor prognosis …
K Suda, I Murakami, T Katayama, K Tomizawa… - Clinical cancer …, 2010 - AACR
Purpose: In epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) therapy for lung cancer patients, acquired resistance develops almost inevitably and this limits the …
SS Ganguly, R Plattner - Genes & cancer, 2012 - journals.sagepub.com
Although c-Abl and Arg non–receptor tyrosine kinases are well known for driving leukemia development, their role in solid tumors has not been appreciated until recently …
Tight regulation of receptor tyrosine kinases (RTKs) is crucial for normal development and homeostasis. Dysregulation of RTKs signaling is associated with diverse pathological …
KS Zeller, O Idevall-Hagren, A Stefansson, T Velling… - Cellular signalling, 2010 - Elsevier
Integrin-mediated cell adhesion activates several signaling effectors, including phosphatidylinositol 3-kinase (PI3K), a central mediator of cell motility and survival. To …
D Mokhtari, A Al-Amin, K Turpaev, T Li… - Diabetologia, 2013 - Springer
Aims/hypothesis It is not clear how small tyrosine kinase inhibitors, such as imatinib mesilate, protect against diabetes and beta cell death. The aim of this study was to …
The c-Abl tyrosine kinase maintains cellular homeostasis through its ability to regulate apoptosis and actin dynamics. In vivo, c-Abl activity is stringently regulated and mechanisms …
Z Blanchard, N Mullins, P Ellipeddi, JM Lage… - PloS one, 2014 - journals.plos.org
Breast cancer is the second leading cause of cancer-related deaths in women. Triple negative breast cancer (TNBC) is an aggressive subtype that affects 10–25% mostly African …
Low-density lipoprotein receptor-related protein 1 (LRP1) is an endocytic and multi- functional type I cell surface membrane protein, which is known to be phosphorylated by the …